tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chiara Russo, 5 are a BUY (50%), 5 are a HOLD (50%).
Analyst Chiara Russo, carries an average stock price target met ratio of 50% that have a potential upside of 44.47% achieved within 267 days. Previously, Chiara Russo worked at CANTOR FITZGERALD.
Chiara Russo’s has documented 19 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BDSI, BioDelivery Sciences International at 16-May-2017.
Analyst best performing recommendations are on ASRT (ASSERTIO THERAPEUTICS).
The best stock recommendation documented was for ASRT (ASSERTIO THERAPEUTICS) at 3/19/2015. The price target of $88 was fulfilled within 7 days with a profit of $11.48 (11.54%) receiving and performance score of 16.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Nov-2024
$35
$23.34 (200.17%)
$3
1 months 24 days ago
(05-Jan-2026)
0/6 (0%)
$25.37 (263.45%)
Buy Since 12-May-2015
$2.75
$-9.03 (-76.66%)
$64
1 years 9 months 1 days ago
(28-May-2024)
2/4 (50%)
$1.75 (175.00%)
317
Buy Since 04-Aug-2023
$4
$-7.66 (-65.69%)
$4
1 years 11 months 17 days ago
(12-Mar-2024)
1/4 (25%)
$-11.15 (-73.60%)
612
Buy Since 04-Aug-2023
$10
2 years 3 months 26 days ago
(03-Nov-2023)
1/1 (100%)
$-33.65 (-77.09%)
606
Hold Since 22-Feb-2017
$16
$4.22 (35.82%)
$52
6 years 6 months 21 days ago
(08-Aug-2019)
0/4 (0%)
$4.76 (42.35%)
What Year was the first public recommendation made by Chiara Russo?
